The pharmaceutical sector is poised for sustained expansion in the foreseeable future, propelled by factors such as the aging demographic, growing chronic illnesses, and technological advancements. Given the backdrop, in this article, we explore the fundamentals of three pharma stocks, Eli Lilly and Company (LLY), Zoetis Inc. (ZTS), and Taro Pharmaceutical Industries Ltd. (TARO), which are being followed by smart money.
According to a report by the IQVIA Institute, the total spending and global demand for medicines will increase to approximately $1.90 trillion by 2027, registering an underlying growth rate of 3-6% in spending. The market is set to be driven by drug launches and wider use of medicines.
